Ahmed Halawa

Ahmed Halawa

Auto-generated profile, based on publicly available information

Ahmed Halawa

Sheffield Teaching Hosp, Sheffield Kidney Inst, Sheffield, S Yorkshire, England

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2018 in World Journal of Transplantation
Verified
Journal Article
Open access
FAFedaey Abbas
Fedaey Abbas
MKMohsen El Kossi
Mohsen El Kossi
JKJon Jin Kim
Jon Jin Kim
ASAjay Sharma
Ajay Sharma
AHAhmed Halawa
Ahmed Halawa
Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease

24 December 2017 in World Journal of Transplantation
Verified
Journal Article
Open access
MAMohammed Mahdi Althaf
Mohammed Mahdi Althaf
MKMohsen El Kossi
Mohsen El Kossi
JJJon Kim Jin
Jon Kim Jin
ASAjay Sharma
Ajay Sharma
AHAhmed Mostafa Halawa
Ahmed Mostafa Halawa
Human leukocyte antigen typing and crossmatch: A comprehensive review

26 August 2019 in World Journal of Transplantation
Verified
Journal Article
Open access
AAAhmed Aref
Ahmed Aref
TZTariq Zayan
Tariq Zayan
RPRavi Pararajasingam
Ravi Pararajasingam
ASAjay Sharma
Ajay Sharma
AHAhmed Halawa
Ahmed Halawa
Pancreatic transplantation: Brief review of the current evidence

1 January 2012 in Annals of Transplantation
Verified
Journal Article
Closed access
PDF file
AHAhmed Halawa
Ahmed Halawa
At present, first and second kidney transplantation have established surgical techniques with few variations between surgeons. They also are considered the best renal replacement therapy for patients with end stage renal disease. Both offer better quality of life and longer survival compared to dialysis. However the third and fourth transplants are significantly more complex. Patients are often highly sensitized, comorbid with limited surgical options due to the previous operations, immunosuppression and long periods on dialysis. There is an incorrect belief that third and fourth retransplantation will not offer any advantage to this cohort of patients and considered to be poor utilization of the limited supply of organs. Recent work demonstrated that third and fourth transplantation offers a survival advantage however it slightly inferior to first and second transplantation, but still there is no established technique. In spite of the surgical challenge, the main cause of graft loss in this cohort of patient is immune mediated rather than the surgical complications. In this review article, we describe various techniques used in transplanting these surgically, immunologically and medically challenging patients demonstrating the effect of surgical complications on the outcome.


24 December 2017 in World Journal of Transplantation
Verified
Journal Article
Open access
FAFedaey Abbas
Fedaey Abbas
MKMohsen El Kossi
Mohsen El Kossi
JJJon Kim Jin
Jon Kim Jin
ASAjay Sharma
Ajay Sharma
AHAhmed Halawa
Ahmed Halawa
De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?